RH
La data pour les RH (compétences, SIRH, GPEC...)
![Absci Absci](https://beta.motherbase.ai/media/logo/142595.jpeg)
Absci
Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by … [voir plus]
![Accrete AI Accrete AI](https://beta.motherbase.ai/media/logo/11086_LnGyjT8.jpeg)
Accrete AI
Unleash Your Genius Accrete AI delivers universally configurable, reliable, and accurate analytical AI agents that perform work that would otherwise require teams of experts and generate insights beyond human capacity. Our vision is to create a path to ethical, reliable, and trustworthy artificial general intelligence by deploying analytical AI agents … [voir plus]
![Antiverse Antiverse](https://beta.motherbase.ai/media/logo/101429.jpeg)
Antiverse
Engineering the future of drug discovery Antiverse is a Welsh techbio start-up specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to save lives. Headquartered in Cardiff, UK and with offices in … [voir plus]
![Atomica AI Atomica AI](https://beta.motherbase.ai/media/logo/174946.jpeg)
Atomica AI
Next-generation digital dentistry solutions using the power of AI Atomica is a US-based startup that helps doctors provide the best patient care possible using the power of AI, Robotics, and 3D Printing. With groundbreaking technology at the core, Atomica is ushering in a new era of patient care - that … [voir plus]
![Atomic AI Atomic AI](https://beta.motherbase.ai/media/logo/174970_CPmWVO6.jpeg)
Atomic AI
Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research … [voir plus]
![BigHat Biosciences BigHat Biosciences](https://beta.motherbase.ai/media/logo/175348_BIbGMIZ.jpeg)
BigHat Biosciences
BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to … [voir plus]
![Bioptimus Bioptimus](https://beta.motherbase.ai/media/logo/194077.jpeg)
Bioptimus
We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models [voir plus]
![conversationHEALTH conversationHEALTH](https://beta.motherbase.ai/media/logo/32080_tKTAxtN.jpeg)
conversationHEALTH
As of January 8, 2024, conversationHEALTH has joined forces with Swoop (www.swoop.com), revolutionizing patient and provider engagement throughout the healthcare industry. This strategic partnership combines conversationHEALTH's expertise in developing advanced conversational AI solutions with Swoop's proficiency in creating precise DTC and HCP audiences. Together, we aim to deliver an unparalleled … [voir plus]
![Evozyne Evozyne](https://beta.motherbase.ai/media/logo/174969_qosiXd9.jpeg)
Evozyne
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. [voir plus]
![Generate:Biomedicines Generate:Biomedicines](https://beta.motherbase.ai/media/logo/175344.jpeg)
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. [voir plus]
![iktos iktos](https://beta.motherbase.ai/media/logo/14671_hZTftQw.jpeg)
iktos
Artificial intelligence for new drug design We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. … [voir plus]
![Insilico Medicine Insilico Medicine](https://beta.motherbase.ai/media/logo/80135.jpeg)
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning … [voir plus]
![JURA Bio, Inc. JURA Bio, Inc.](https://beta.motherbase.ai/media/logo/174968_kacC0ns.jpeg)
JURA Bio, Inc.
Building the future of cell-based therapies. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and Machine Learning [voir plus]
![MDClone MDClone](https://beta.motherbase.ai/media/logo/175346.jpeg)
MDClone
Unlock healthcare data. Transform care. See #syntheticdata in action. See an ADAMS Platform demo today: Link in bio MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome … [voir plus]
![Owkin Owkin](https://beta.motherbase.ai/media/logo/8018_1X1wCKZ.jpeg)
Owkin
We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing … [voir plus]
![Paige Paige](https://beta.motherbase.ai/media/logo/175347.jpeg)
Paige
Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a … [voir plus]
![PictorLabs Inc PictorLabs Inc](https://beta.motherbase.ai/media/logo/174965.jpeg)
PictorLabs Inc
Histopathology reimagined. PictorLabs, Inc. is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence, and health-tech product development, the Company is reimagining existing histopathology … [voir plus]
![Profluent Profluent](https://beta.motherbase.ai/media/logo/174932.jpeg)
Profluent
Decoding the language of life with AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Berkeley, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, … [voir plus]
![Redesign Science Redesign Science](https://beta.motherbase.ai/media/logo/174967.jpeg)
Redesign Science
Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic … [voir plus]
![Syntegra Syntegra](https://beta.motherbase.ai/media/logo/174918.jpeg)
Syntegra
Democratizing healthcare data to dramatically accelerate how treatments reach patients. Syntegra is unlocking the promise of real-world evidence by employing a groundbreaking machine learning model — the Syntegra Medical Mind — to enable low-burden access to privacy-preserved and equitable synthetic health data, increasing the value of data for those who … [voir plus]
![Valence Labs Valence Labs](https://beta.motherbase.ai/media/logo/17745_9NvS03S.jpeg)
Valence Labs
Industrializing scientific discovery to radically improve lives. Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) … [voir plus]
![Wysa Wysa](https://beta.motherbase.ai/media/logo/63404_C0eUcRO.jpeg)
Wysa
Global leader in AI-driven mental health support, NHS (ORCHA) certified, FDA Breakthrough Device Designation. Wysa is an AI-enabled Coach for mental and emotional wellness. Launched in 2017, the service provides early intervention to high-risk groups through 3 methods: - An AI chatbot - A library of evidence-based self-help tools - … [voir plus]